NCT07256717 BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
| NCT ID | NCT07256717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc. |
| Condition | Physical Fitness |
| Study Type | INTERVENTIONAL |
| Enrollment | 369 participants |
| Start Date | 2025-10-10 |
| Primary Completion | 2026-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 369 participants in total. It began in 2025-10-10 with a primary completion date of 2026-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, multi-site, single-arm interventional study evaluates the 5-Line Principle of Balanced Progressive Intensity Training (BPIT) over 5 weeks in healthy adults aged 18-65 years. All participants receive supervised BPIT sessions (3-5 per week) progressing through five intensity lines defined by anatomical landmarks and ground reaction force: Ground-Based (Low) Knee-Level (Low-Moderate) Standing (Moderate) Head-Level (Moderate-High) Plyometric (High-Impact) The study aims to quantify improvements in functional movement efficiency, joint mobility, postural control, strength adaptation, and heart-rate variability while monitoring safety and individual overload indicators.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18-65 years Generally healthy with regular physical activity history (at least 1-2 sessions per week for the past 3 months) Able to commit to 3-5 supervised training sessions per week for 5 weeks Willing and able to provide written informed consent Cleared by pre-screening (no acute injury, no contraindications) Exclusion Criteria: * Acute musculoskeletal injury within the past 3 months Known cardiovascular, metabolic, or orthopaedic conditions that contraindicate exercise Pregnancy or planning pregnancy Use of medications or supplements that significantly affect muscle recovery or performance (e.g., corticosteroids, anabolic agents) Inability to follow the BPIT protocol or attend required sessions
Frequently Asked Questions
Who can join the NCT07256717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Physical Fitness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07256717 currently recruiting?
Yes, NCT07256717 is actively recruiting participants. Visit ClinicalTrials.gov or contact MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc. to inquire about joining.
Where is the NCT07256717 trial being conducted?
This trial is being conducted at Columbus, United States, Powell, United States, Powell, United States, Burhānpur, India and 6 additional locations.
Who is sponsoring the NCT07256717 clinical trial?
NCT07256717 is sponsored by MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc.. The trial plans to enroll 369 participants.